How High Can SharkNinja Stock Go?
If you know popular consumer appliance brands Shark and Ninja,…
Sell
2
ICU Quote, Financials, Valuation and Earnings
Last price:
$0.55
Seasonality move
:
-25.5%
Day range:
$0.51 - $0.59
52-week range:
$0.31 - $9.56
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
10.50x
Volume:
1.6M
Avg. volume:
12.9M
1-year change:
-93.49%
Market cap:
$5.9M
Revenue:
$135K
EPS (TTM):
-$3.47
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, SeaStar Medical Holding has 1150% upside to fair value with a price target of $7.00 per share.
ICU vs. S&P 500
-
Over the past 5 trading days, SeaStar Medical Holding has overperformed the S&P 500 by 1.97% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
SeaStar Medical Holding does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
SeaStar Medical Holding has grown year-over-year revenues for 0 quarters straight. In the most recent quarter SeaStar Medical Holding reported revenues of $293K.
Earnings Growth
-
SeaStar Medical Holding has grown year-over-year earnings for 0 quarters straight. In the most recent quarter SeaStar Medical Holding reported earnings per share of -$0.44.
Enterprise value:
998.2K
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.07x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
-1304.44%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | $293K | |
| Gross Profit | -- | -- | -- | -- | $293K | |
| Operating Income | -$15.4M | -$13.6M | -$17.7M | -$4M | -$3.8M | |
| EBITDA | -$17.4M | -$31M | -$15.8M | -$12.6M | -$3.8M | |
| Diluted EPS | -$35.52 | -$22.82 | -$3.47 | -$4.73 | -$0.44 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $425K | $3.4M | $6.5M | $6.8M | |
| Total Assets | -- | $427K | $3.4M | $7.7M | $7.6M | |
| Current Liabilities | -- | $3.7M | $8M | $9.6M | $7M | |
| Total Liabilities | -- | $77.6M | $14.3M | $12.2M | $7M | |
| Total Equity | -- | -$77.2M | -$10.9M | -$4.5M | $565K | |
| Total Debt | -- | -- | -- | -- | $363K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$9.5M | -$11.5M | -$15.2M | -$3.5M | -$2.7M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | $10M | $15.8M | $15.5M | $8.3M | $6.1M | |
| Free Cash Flow | -$9.5M | -$11.5M | -$15.2M | -$3.5M | -$2.7M | |
ICU
Sector
Market Cap
$5.9M
$34.5M
Price % of 52-Week High
5.86%
49.05%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.01%
1-Year Price Total Return
-93.49%
-35.15%
Beta (5-Year)
--
0.615
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.62
200-day SMA
Sell
Level
$2.00
Bollinger Bands (100)
Sell
Level
0.84 - 1.8
Chaikin Money Flow
Buy
Level
11.4M
20-day SMA
Sell
Level
$0.62
Relative Strength Index (RSI14)
Sell
Level
39.12
ADX Line
Buy
Level
14.59
Williams %R
Neutral
Level
-60.4811
50-day SMA
Sell
Level
$0.99
MACD (12, 26)
Buy
Level
0.15
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Neutral
Level
6.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-59.1093)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (1)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (1)
Revenue Forecast
Earnings per Share Forecast
Company Profile
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
Stock Forecast FAQ
In the current month, ICU has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ICU average analyst price target in the past 3 months is $7.00.
-
Where Will SeaStar Medical Holding Stock Be In 1 Year?
According to analysts, the consensus estimate is that SeaStar Medical Holding share price will rise to $7.00 per share over the next 12 months.
-
What Do Analysts Say About SeaStar Medical Holding?
Analysts are divided on their view about SeaStar Medical Holding share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that SeaStar Medical Holding is a Sell and believe this share price will drop from its current level to $7.00.
-
What Is SeaStar Medical Holding's Price Target?
The price target for SeaStar Medical Holding over the next 1-year time period is forecast to be $7.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ICU A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for SeaStar Medical Holding is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ICU?
You can purchase shares of SeaStar Medical Holding via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase SeaStar Medical Holding shares.
-
What Is The SeaStar Medical Holding Share Price Today?
SeaStar Medical Holding was last trading at $0.55 per share. This represents the most recent stock quote for SeaStar Medical Holding. Yesterday, SeaStar Medical Holding closed at $0.56 per share.
-
How To Buy SeaStar Medical Holding Stock Online?
In order to purchase SeaStar Medical Holding stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Oklo Stock Double?
Oklo (NYSE: OKLO) is only a year removed from its SPAC‑enabled debut,…
Why a $5 Stock Is Suddenly a Cash Machine
If you stopped tracking Grab Holdings (NASDAQ: GRAB) after its 2021 SPAC…
Stock Ideas
Buy
69
Is NVDA Stock a Buy?
Market Cap: $4T
P/E Ratio: 56x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Alerts
Buy
77
VBTX alert for Jul 15
Veritex Holdings [VBTX] is down 3.26% over the past day.
Buy
72
MNPR alert for Jul 15
Monopar Therapeutics [MNPR] is down 8.6% over the past day.
Buy
56
NBIS alert for Jul 15
Nebius Group NV [NBIS] is up 2.98% over the past day.
